PL2817312T3 - Nowe związki będące antagonistami receptora neurokininy 1 - Google Patents
Nowe związki będące antagonistami receptora neurokininy 1Info
- Publication number
- PL2817312T3 PL2817312T3 PL13720801T PL13720801T PL2817312T3 PL 2817312 T3 PL2817312 T3 PL 2817312T3 PL 13720801 T PL13720801 T PL 13720801T PL 13720801 T PL13720801 T PL 13720801T PL 2817312 T3 PL2817312 T3 PL 2817312T3
- Authority
- PL
- Poland
- Prior art keywords
- receptor antagonist
- antagonist compounds
- novel neurokinin
- neurokinin
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261601902P | 2012-02-22 | 2012-02-22 | |
PCT/EP2013/053319 WO2013124286A1 (en) | 2012-02-22 | 2013-02-20 | Novel neurokinin 1 receptor antagonist compounds |
EP13720801.3A EP2817312B1 (en) | 2012-02-22 | 2013-02-20 | Novel neurokinin 1 receptor antagonist compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2817312T3 true PL2817312T3 (pl) | 2016-08-31 |
Family
ID=48325586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13720801T PL2817312T3 (pl) | 2012-02-22 | 2013-02-20 | Nowe związki będące antagonistami receptora neurokininy 1 |
Country Status (17)
Country | Link |
---|---|
US (1) | US9181259B2 (pl) |
EP (1) | EP2817312B1 (pl) |
JP (1) | JP6111274B2 (pl) |
KR (1) | KR20140122764A (pl) |
CN (1) | CN104245702B (pl) |
AU (1) | AU2013224181A1 (pl) |
CA (1) | CA2864440A1 (pl) |
DK (1) | DK2817312T3 (pl) |
ES (1) | ES2568909T3 (pl) |
HK (1) | HK1205104A1 (pl) |
MX (1) | MX2014010012A (pl) |
PL (1) | PL2817312T3 (pl) |
RU (1) | RU2631319C2 (pl) |
SG (1) | SG11201404880UA (pl) |
TW (1) | TW201339161A (pl) |
WO (1) | WO2013124286A1 (pl) |
ZA (1) | ZA201405959B (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2817312T3 (pl) * | 2012-02-22 | 2016-08-31 | Leo Pharma As | Nowe związki będące antagonistami receptora neurokininy 1 |
CA2884454C (en) | 2012-10-11 | 2021-07-27 | Nerre Therapeutics Limited | Orvepitant and uses thereof |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
WO2015024203A1 (en) * | 2013-08-20 | 2015-02-26 | Leo Pharma A/S | Novel neurokinin 1 receptor antagonist compounds ii |
ES2871036T3 (es) * | 2015-11-09 | 2021-10-28 | Ngm Biopharmaceuticals Inc | Método para el tratamiento de trastornos relacionados con ácidos biliares |
MX2018016400A (es) * | 2016-06-29 | 2019-09-02 | Menlo Therapeutics Inc | Uso de antagonistas de neuroquinina 1 para tratar una variedad de afecciones pruríticas. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923748D0 (en) * | 1999-10-07 | 1999-12-08 | Glaxo Group Ltd | Chemical compounds |
GB0025354D0 (en) | 2000-10-17 | 2000-11-29 | Glaxo Group Ltd | Chemical compounds |
GB0108595D0 (en) | 2001-04-05 | 2001-05-23 | Glaxo Group Ltd | Chemical compounds |
GB0203020D0 (en) * | 2002-02-08 | 2002-03-27 | Glaxo Group Ltd | Chemical compounds |
UA77515C2 (en) * | 2002-04-04 | 2006-12-15 | Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity | |
US7652058B2 (en) * | 2004-12-14 | 2010-01-26 | Merck Sharp & Dohme Corp. | Octahydropyrano[3,4-C]pyrrole tachykinin receptor antagonists |
KR20090112722A (ko) | 2007-01-24 | 2009-10-28 | 글락소 그룹 리미티드 | 3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 r(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 nk1을 포함하는 제약 조성물 |
WO2009002770A1 (en) | 2007-06-22 | 2008-12-31 | Merck & Co., Inc. | 6.5-pyrrolopiperidine tachykinin receptor antagonists |
PL2817312T3 (pl) * | 2012-02-22 | 2016-08-31 | Leo Pharma As | Nowe związki będące antagonistami receptora neurokininy 1 |
-
2013
- 2013-02-20 PL PL13720801T patent/PL2817312T3/pl unknown
- 2013-02-20 DK DK13720801.3T patent/DK2817312T3/en active
- 2013-02-20 WO PCT/EP2013/053319 patent/WO2013124286A1/en active Application Filing
- 2013-02-20 JP JP2014558082A patent/JP6111274B2/ja not_active Expired - Fee Related
- 2013-02-20 AU AU2013224181A patent/AU2013224181A1/en not_active Abandoned
- 2013-02-20 KR KR1020147026352A patent/KR20140122764A/ko not_active Application Discontinuation
- 2013-02-20 SG SG11201404880UA patent/SG11201404880UA/en unknown
- 2013-02-20 MX MX2014010012A patent/MX2014010012A/es unknown
- 2013-02-20 US US14/380,078 patent/US9181259B2/en not_active Expired - Fee Related
- 2013-02-20 CN CN201380021175.4A patent/CN104245702B/zh not_active Expired - Fee Related
- 2013-02-20 CA CA2864440A patent/CA2864440A1/en not_active Abandoned
- 2013-02-20 EP EP13720801.3A patent/EP2817312B1/en not_active Not-in-force
- 2013-02-20 RU RU2014138032A patent/RU2631319C2/ru not_active IP Right Cessation
- 2013-02-20 ES ES13720801T patent/ES2568909T3/es active Active
- 2013-02-21 TW TW102106062A patent/TW201339161A/zh unknown
-
2014
- 2014-08-14 ZA ZA2014/05959A patent/ZA201405959B/en unknown
-
2015
- 2015-06-08 HK HK15105430.0A patent/HK1205104A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2817312B1 (en) | 2016-02-17 |
US9181259B2 (en) | 2015-11-10 |
JP6111274B2 (ja) | 2017-04-05 |
CN104245702A (zh) | 2014-12-24 |
WO2013124286A1 (en) | 2013-08-29 |
CN104245702B (zh) | 2016-09-14 |
MX2014010012A (es) | 2014-09-12 |
CA2864440A1 (en) | 2013-08-29 |
ES2568909T3 (es) | 2016-05-05 |
EP2817312A1 (en) | 2014-12-31 |
RU2631319C2 (ru) | 2017-09-21 |
SG11201404880UA (en) | 2014-09-26 |
KR20140122764A (ko) | 2014-10-20 |
ZA201405959B (en) | 2016-08-31 |
TW201339161A (zh) | 2013-10-01 |
AU2013224181A1 (en) | 2014-10-02 |
RU2014138032A (ru) | 2016-04-10 |
HK1205104A1 (en) | 2015-12-11 |
JP2015511240A (ja) | 2015-04-16 |
US20150018345A1 (en) | 2015-01-15 |
DK2817312T3 (en) | 2016-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1203191A1 (en) | P2x4 receptor antagonist p2x4 | |
HK1252279A1 (zh) | 5- ht3受體拮抗劑 | |
EP2665707A4 (en) | Mineralocorticoid receptor antagonists | |
SI2862860T1 (sl) | Spojine 1,3-oksazolidina ali 1,3-oksazinana kot antagonisti receptorja oreksina | |
HK1205104A1 (en) | Novel neurokinin receptor antagonist compounds | |
HK1203938A1 (en) | Novel 2h-indazoles as ep2 receptor antagonists ep2 2h- | |
HK1192228A1 (zh) | 受體拮抗劑 | |
EP2765860A4 (en) | Mineralocorticoid receptor antagonists | |
EP2697203A4 (en) | ANTAGONISTS OF MINERALOCORTICOID RECEPTORS | |
EP2874621A4 (en) | Mineralocorticoid receptor antagonists | |
EP2765859A4 (en) | Mineralocorticoid receptor antagonists | |
IL231413A0 (en) | Toll-like receptor 3 antagonists | |
EP2765858A4 (en) | ANTAGONISTS OF A MINERALOCORTICOID RECEPTOR | |
GB201213699D0 (en) | Receptor antagonists II | |
GB201213698D0 (en) | Receptor antagonists II | |
GB201220558D0 (en) | Novel compounds 1 | |
GB201206730D0 (en) | Novel compounds 1 |